Trial Profile
Phase II Multicentre, Randomised, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation, Effect on it Own and in Combination With Open Label Nicotine Replacement Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2014
Price :
$35
*
At a glance
- Drugs Sembragiline (Primary) ; Nicotine
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Sponsors Evotec NeuroSciences
- 25 Jun 2014 New trial record